CN Patent

CN113423384B — Cnp缀合物的干燥药物制剂

Assigned to Ascendis Pharma Endocrinology Division AS · Expires 2024-01-05 · 2y expired

What this patent protects

一种干燥药物制剂，其中所述药物制剂包含CNP缀合物、缓冲剂和填充剂，且其中所述CNP缀合物包含共价和可逆地缀合至聚合物部分的CNP部分。

USPTO Abstract

一种干燥药物制剂，其中所述药物制剂包含CNP缀合物、缓冲剂和填充剂，且其中所述CNP缀合物包含共价和可逆地缀合至聚合物部分的CNP部分。

Drugs covered by this patent

Patent Metadata

Patent number: CN113423384B
Jurisdiction: CN
Classification: —
Expires: 2024-01-05
Drug substance claim: No
Drug product claim: No
Assignee: Ascendis Pharma Endocrinology Division AS
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.